Feedback

X

Explore

Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression

Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression

0 Ungluers have Faved this Work
The aim of this Special Issue is to collect reports regarding all the recent strategies, directed at the improvement of antineoplastic activity of drugs in cancer progression, engaging all the expertise needed for the development of new anticancer drugs: medicinal chemistry, pharmacology, molecular biology, and computational and drug delivery studies.

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.

Downloads

This work has been downloaded 20 times via unglue.it ebook links.
  1. 20 - pdf (CC BY) at Unglue.it.

Keywords

  • (E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile
  • acetamidophenones
  • acute myelogenous leukemia
  • ADMET analysis
  • aldehyde dehydrogenase
  • aminopeptidase N
  • anticancer
  • antiparasitic therapy
  • Apoptosis
  • Arylquin 1
  • Autophagy
  • azelastine
  • Biology, Life Sciences
  • biomarkers
  • biotin targeting
  • biphenylnicotinamide derivatives
  • brain tumor
  • cell invasion
  • cell penetrating peptide
  • chemical synthesis
  • chronic myeloid leukemia
  • cisplatin resistance
  • clathrin
  • colon cancer
  • colorectal adenocarcinoma
  • colorectal cancer
  • combination therapy
  • CTC
  • ctDNA
  • cyclodextrin inclusion complex
  • cyclophosphamide
  • CYP2D6
  • cytotoxic activity
  • Cytotoxicity
  • dicarboximides
  • diclofenac
  • disulfiram
  • doxorubicin
  • doxorubicin resistance
  • Drug delivery
  • drug efflux transporter
  • dual inhibitor
  • early detection examination
  • EGFR
  • Egr-1
  • elastin-like polypeptide
  • Endocytosis
  • epithelial to mesenchymal transition
  • Exosomes
  • extracellular vesicles
  • flavonoid
  • FTIR spectroscopy
  • gastric cancer
  • gene profiling
  • Glioblastoma
  • glioblastoma multiforme
  • imatinib
  • immune checkpoint inhibitor
  • Immunotherapy
  • indomethacin
  • Inflammation
  • inhibition of proliferation
  • Ishikawa cells
  • isothiocyanates
  • Ketoconazole
  • kinases
  • leukemias
  • ligand-based pharmacophore
  • Liquid Biopsy
  • MAPKs
  • Mathematics & science
  • matrix metalloproteinase
  • MCF-7
  • MDA-MB-231
  • metalloproteinase-9
  • metronomic therapy
  • microparticles
  • mitotic catastrophe
  • MMP9
  • molecular docking
  • Molecular Dynamics
  • molecular iodine
  • MTT assay
  • Neuroblastoma
  • NF-κB
  • Nicotine
  • NMR spectroscopy thermogravimetric analysis
  • non-small-cell lung cancer
  • Nrf2
  • oleanolic acid derivative conjugates
  • Oxidative Stress
  • P-Glycoprotein
  • paclitaxel
  • PAMAM dendrimer
  • Pancreatic Cancer
  • pancreatic ductal adenocarcinoma
  • personalized medicine
  • phase solubility studies
  • photodynamic therapy
  • photosensitizer delivery system
  • phototoxicity
  • platelets
  • poly(amidoamine) dendrimer
  • preformulation studies
  • PSN-1 cells
  • pyrazole derivatives
  • Reactive Oxygen Species
  • Reference, information & interdisciplinary subjects
  • Research & information: general
  • SAR
  • Schiff bases
  • semicarbazones
  • SERM
  • single-crystal diffraction
  • squamous cell carcinoma
  • sulforaphane
  • tamoxifen
  • Targeted Drug Delivery
  • thiosemicarbazones
  • TNBC
  • TNFα
  • Tumor microenvironment
  • tumor progression
  • tumor resistance
  • tumor targeting
  • tumor treatment
  • tyrosine kinase
  • uterotrophic
  • VEGFR2
  • Xenografts
  • α-mangostin
  • γδ T cells

Links

DOI: 10.3390/books978-3-0365-5927-8

Editions

edition cover

Share

Copy/paste this into your site: